CGM vs Blood Tests for Glucose Monitoring in Perimenopause: What Tells You More?
Compare continuous glucose monitors (Libre, Dexcom) vs fasting blood glucose and HbA1c for tracking metabolic health in perimenopause. Cost, insights, and practicalities.
Why Metabolic Monitoring Matters in Perimenopause
Perimenopause significantly affects glucose metabolism. Declining oestrogen reduces insulin sensitivity, increases abdominal fat accumulation, and raises the risk of developing insulin resistance and type 2 diabetes. Studies show that the risk of metabolic syndrome increases substantially during the menopausal transition, independent of ageing and body weight. For women who are gaining weight around the abdomen, experiencing energy crashes, craving sugar or carbohydrates, or noticing worsening fatigue after meals, understanding their glucose dynamics has real clinical value. The two main approaches to glucose monitoring are periodic blood tests, including fasting glucose and HbA1c ordered by a GP, and continuous glucose monitors (CGMs), small wearable sensors applied to the upper arm or abdomen that track interstitial glucose levels in real time. These tools answer different questions, have different costs and accessibility, and suit different situations. Neither replaces the other entirely, but for many perimenopausal women, understanding what each can and cannot reveal makes it easier to choose the right tool for their specific needs.
Standard Blood Tests: Fasting Glucose and HbA1c
A fasting blood glucose test measures your blood sugar level after at least eight hours without food. A result below 5.6 mmol/L is normal, 5.6 to 6.9 is impaired fasting glucose (prediabetes territory), and 7.0 or above indicates possible diabetes requiring confirmation. HbA1c reflects average blood glucose over the preceding two to three months by measuring the percentage of haemoglobin that has been glycated. An HbA1c below 42 mmol/mol is normal, 42 to 47 is prediabetes range, and 48 or above is consistent with diabetes. These tests are available through NHS GPs at no direct cost to the patient, and they are the standard screening tools for identifying impaired glucose regulation. Their limitation is that they capture only snapshots or averages. Fasting glucose tells you nothing about how your blood sugar responds to a meal, how it behaves overnight, or what your post-exercise glucose looks like. A woman can have a normal fasting glucose and HbA1c while experiencing significant glycaemic variability and post-meal spikes that affect energy, mood, and appetite regulation.
Continuous Glucose Monitors: What They Track and How They Work
CGMs such as the Abbott FreeStyle Libre (Libre 2 and Libre 3) and Dexcom G7 use a small filament inserted just under the skin, typically on the upper arm, to measure interstitial glucose approximately every minute. Data is transmitted via Bluetooth to a smartphone or reader, providing a continuous glucose trace throughout the day and night. This allows users to see how specific foods, meals, exercise, stress, sleep quality, and alcohol affect their glucose levels in real time. For perimenopausal women without diabetes, CGMs are used off-label as metabolic health awareness tools. The insights they generate can be genuinely transformative: many women discover that foods they considered healthy, such as certain breakfast cereals, rice cakes, fruit juices, or smoothies, cause significant glucose spikes, while foods they had avoided are relatively glucose-neutral for their individual physiology. CGMs also reveal nocturnal glucose patterns, which can be relevant for women whose night sweats and sleep disruption correlate with glucose fluctuations.
Cost, Availability, and Practical Considerations
Blood tests ordered by a GP are free on the NHS. CGMs, by contrast, are not NHS-funded for non-diabetic use and must be purchased privately. The FreeStyle Libre 2 sensor lasts 14 days and costs approximately 47 to 55 pounds per sensor in the UK (2025 prices). A Libre 3 sensor for 15 days is similarly priced. Dexcom G7 sensors are slightly more expensive. Many women try one or two sensors, typically for four to eight weeks, to gather a baseline understanding of their glucose patterns, then retest seasonally or after dietary changes rather than wearing a CGM continuously. The data from a CGM is most useful when interpreted alongside nutritional context, and several apps including Zoe, Levels, and January AI have been built specifically to help non-diabetic users interpret CGM data and make dietary adjustments. These subscription services add a further monthly cost. The combined investment of two sensors plus an app subscription can run to 150 to 200 pounds for a meaningful assessment period. For women with a strong metabolic health concern or family history of diabetes, this cost may be well justified.
What Blood Tests Tell You That CGMs Cannot, and Vice Versa
Blood tests and CGMs are complementary rather than competing tools. HbA1c provides a validated, clinically recognised measure of average glycaemia that is essential for diagnosing prediabetes or diabetes, and it is what GPs and specialists use to guide clinical decisions. No CGM-derived metric replaces HbA1c for clinical diagnostic purposes. Blood tests also include fasting insulin measurements, which combined with fasting glucose allow calculation of HOMA-IR (Homeostatic Model Assessment of Insulin Resistance), a useful marker that CGMs cannot provide. Conversely, CGMs reveal post-meal glucose peaks (which can be significantly elevated even when fasting glucose and HbA1c are normal), overnight patterns, hypoglycaemic dips, and the glycaemic impact of specific foods, stress, and exercise that blood tests simply cannot capture. For women whose GP blood tests come back as normal but who feel unwell and suspect metabolic issues, a trial period with a CGM can provide data that either reassures or identifies patterns worth investigating further with a clinician.
Practical Recommendations for Perimenopausal Women
A sensible approach for most perimenopausal women is to start with standard GP blood tests, including fasting glucose, HbA1c, and ideally fasting insulin, as a baseline. These are free, clinically validated, and give your GP the information needed to assess diabetes risk and guide any necessary intervention. If your results are normal but you continue to experience energy instability, persistent fatigue, strong carbohydrate cravings, or symptoms you suspect may be metabolically driven, a one-to-two sensor trial with a CGM (four to eight weeks) gives you a detailed picture of your individual glucose responses that no blood test can provide. Use the CGM data to identify your personal high-spike foods and meals, and test whether dietary adjustments such as eating protein before carbohydrate, adding fibre and fat to meals, or walking after eating improve your glucose stability. Share any significant CGM findings with your GP or a registered dietitian, who can help interpret the data in the context of your broader health. Pairing CGM insights with resistance training, good sleep, and an HRT regimen that addresses your hormonal status represents the most comprehensive metabolic management strategy available for perimenopausal women.
Related reading
Get your personalized daily plan
Track symptoms, match workouts to your day type, and build a routine that adapts with you through every phase of perimenopause.